The sIL-6R/sgp130 ratio could be evaluated as a differential diagnostic tool between BPH and PCa in relation to PSA as urologists continue the quest for the ideal tumor marker, but further studies will be needed [49]. The gene discussed is IL6R; the disease is neoplasm.